HuGE Literature Finder
Records
1
-
2
CPS1 T1405N polymorphism, HDL cholesterol, homocysteine and renal function are risk factors of VPA induced hyperammonemia among epilepsy patients. Epilepsy research 2019 May 154 139-143. Chen Lanlan, Tian Qiuxiang, Zhang Miaoran, Chen Deyu, Gao Xue, Yang Hongqun, Li Haitao, Li Chengnan, Wen Jianping, Li Yulin, Tian Xin, Chen Pe |
4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy. Epilepsy research 2014 Aug 108 (6): 1046-51. Inoue Kazuyuki, Suzuki Eri, Takahashi Toshiki, Yamamoto Yoshiaki, Yazawa Rei, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Inoue Yushi, Tsuji Daiki, Hayashi Hideki, Itoh Kunihi |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: